Updated Results On Heart Assist Device Presented At International Transplant Meeting

Includes Data Submitted For FDA Approval Of Novacor® System

SAN FRANCISCO, April 23 -- Results of a study of more than 150 patients sustained on the Novacor® Left Ventricular Assist System (LVAS) as a "bridge" to transplantation were presented for the first time at the International Society for Heart and Lung Transplantation (ISHLT) annual meeting today. The findings, which represent experiences of 22 U.S. transplant centers, included data that served as the basis for U.S. Food and Drug Administration (FDA) approval of the system less than a year ago. The Novacor LVAS is a product of the Cardiovascular Group of Baxter Healthcare Corporation.

Those patients who were discharged from the hospital with the Novacor LVAS while waiting for donor hearts fared better than patients whose medical condition required them to stay in the hospital, reported Robert Kormos, M.D., associate professor of surgery and director of the artificial heart and adult transplantation program at the University of Pittsburgh Medical Center (UPMC). About a third of the patients (29 percent) waited outside the hospital, six for more than a year and two for more than two years, allowing them the opportunity to lead normal, productive lives.

"The clinical experience with the discharged patients indicates there is improved quality of life and highlights the safety and feasibility for long-term use," said Dr. Kormos, a principal investigator of the multi-center trial.

With the number of patients being placed on transplant waiting lists growing each year but the supply of available organs remaining relatively stagnant, artificial assist devices serve a critical function by providing patients a means to sustain heart function until human donor hearts can be found. There are currently more than 4,200 patients on the national heart transplant waiting list, according to the United Network for Organ Sharing, and waiting times can exceed two or three year

Contact: Lisa Rossi
University of Pittsburgh Medical Center

Page: 1 2 3

Related medicine news :

1. Updated adjuvant data presented at SABCS show 30 percent reduction in recurrence
2. Updated press release to October 2004 Cochrane Review
3. Updated data compares DOXIL (R)/CAELYX (TM) (doxorubicin HCl liposome injection) to Topotecan
4. Newly Updated HIV Treatment Guidelines For Adults And Adolescents Available On The World Wide Web
5. Heart transplant survival: Results may be key to rejection prevention, detection, treatment
6. Docetaxel versus paclitaxel in breast cancer Results of worlds first head to head trial
7. Results from first clinical trial using GVG to treat addiction
8. Results of first chronic treatment study with oral EXANTA(TM) (ximelagatran)
9. Media Advisory-- Results of California autism epidemiology study to be unveiled
10. Results of Yale study confirm aspirin helpful in preventing a first heart attack
11. Results of NUVANCE (IL-4 receptor) in Phase I/II study in asthma patients featured at AAAAI Late-Breaker Abstract and Asthma Therapy Sessions

Post Your Comments:

(Date:7/2/2020)... ... July 02, 2020 , ... The ... offices for non-emergency work. In conjunction with the American Dental Association and Centers ... practices in mid-May. , Due to safety concerns, the announcement sparked hesitancy ...
(Date:7/1/2020)... ... 2020 , ... ABSTRAX, an industry leader in the study ... terpene infused product line including custom rolling papers, cones, flat wraps, and blunts ... flavors worldwide. , “We’ve made it easier than ever for brands to take ...
(Date:7/1/2020)... ... July 01, 2020 , ... The Society to ... of Medicine at the University of Massachusetts Medical School- Baystate and Ann Gaffey, ... the SIDM Board of Directors. Dr. Salvador and Ms. Gaffey’s service began in ...
(Date:6/28/2020)... ... June 26, 2020 , ... The Pool & Hot Tub ... of the ANSI/APSP/ICC-7 2013 American National Standard for Suction Entrapment Avoidance In Swimming ... participation on the PHTA-7 Standard Writing Committee (SWC) for Suction Entrapment Avoidance in ...
(Date:6/28/2020)... ... ... PathAI, a global provider of artificial intelligence (AI)-powered technology for use in pathology ... expression to assess response in patients treated with Bristol Myers Squibb’s PD-1 inhibitor, nivolumab ... (AACR) Annual Meeting. AACR was held June 22 to June 24. , The key ...
Breaking Medicine News(10 mins):
(Date:7/1/2020)... SAN FRANCISCO (PRWEB) , ... July 01, 2020 ... ... for the first time ever, Stratodesk NoTouch OS is available on NComputing devices. ... NComputing device, both NComputing and Stratodesk have formed a new partnership that will ...
(Date:6/28/2020)... NEW YORK (PRWEB) , ... June 26, 2020 ... ... this June’s 'Lung Health' campaign. The campaign brings together patients, healthcare providers, advocates, ... innovations in diagnostics, prevention, and treatment for these devastating respiratory conditions. ...
(Date:6/25/2020)... ... ... R3 Medical Training announced today it is now enrolling for its new ... course is August 6-7, 2020 in San Diego and the second is August 20-21, ... Stream option. , The two day agenda for each course is identical, covering a ...
Breaking Medicine Technology:
Cached News: